Loading organizations...
§ Venture Capital · New York City, NY, USA
Early-stage venture capital firm investing in pre-seed and seed technology startups, focused on diverse founders and social impact.
Key people at Benchstrength.
Benchstrength is a New York City-based early-stage venture capital firm that provides equity financing to pre-seed and seed-stage technology companies. The firm primarily targets startups operating across the enterprise software, consumer technology, financial technology, and digital healthcare sectors. As part of its core investment strategy, the organization focuses on generating returns while supporting founders who have been historically overlooked by traditional venture capital networks. Benchstrength currently operates with a $62 million debut fund and has established an active investment portfolio consisting of approximately 20 early-stage technology companies. The firm's institutional capital base is backed by prominent individual investors including Henry Kravis, Ursula Burns, and Ron Conway, while its portfolio features emerging startups such as Paces and Firsthand. Benchstrength was officially founded in 2021 by former venture capital partners Ken Chenault Jr. and John Monagle.
Key people at Benchstrength.
Benchstrength is a New York City–based early-stage venture capital firm founded in 2022 by former General Catalyst investors Ken Chenault Jr. and John Monagle. The firm’s mission is to invest in high-potential technology startups that transform business and uplift communities, focusing on pre-seed and seed-stage companies primarily in enterprise, fintech, healthcare, and consumer sectors. Benchstrength emphasizes sustainability, operational excellence, and diversity, supporting founders often overlooked by traditional venture capital networks. Since its inception, it has raised a $62 million fund backed by prominent institutional and individual investors and built a portfolio of about 20 companies, including AI-driven startups in pharma, personal styling, wealth management, and women’s healthcare[1][2][3][4].
Benchstrength was founded in 2022 by Ken Chenault Jr. and John Monagle, who met at Harvard Business School and previously worked together at General Catalyst. Their combined decades of investing experience shaped the firm’s focus on early-stage tech companies with strong growth potential and social impact. The firm has evolved to emphasize diversity and inclusion alongside financial returns, leveraging a network of experienced partners and institutional backers. Key team members include Principal Kendra Schultz and Head of Network Aleksandra Imbasciani, who contribute to sourcing and supporting portfolio companies[1][2][3][5].
Benchstrength rides the growing trend of early-stage venture capital focusing on technology companies that combine innovation with social impact. The timing is favorable due to increasing investor interest in diversity, sustainability, and healthcare innovation, alongside fintech and enterprise software growth. By backing diverse founders and transformative technologies, Benchstrength influences the startup ecosystem by expanding access to capital and operational resources, helping shape a more inclusive and sustainable tech landscape[2][3].
Looking ahead, Benchstrength is poised to continue scaling its influence by deploying capital into emerging technology sectors with strong societal impact. Trends such as AI integration in healthcare and fintech, increasing demand for sustainable business models, and a focus on diversity in entrepreneurship will likely shape its investment strategy. As the firm matures, its role as a bridge between institutional capital and underrepresented founders could deepen, further amplifying its impact on the venture ecosystem and the broader technology landscape[3][4].
Benchstrength has more than 26 tracked investments across 26 companies. The latest tracked deal is $25.0M Series A in Knox in March 2026.
